However, an alternative homologous recombination-based and telomerase-independent mechanism, known as Alternative Lengthening of Telomeres (ALT), is frequently activated in rarer cancer types, including sarcomas, astrocytomas, glioblastomas or neuroendocrine pancreatic cancers [2]. Here, GPT is linked to sarcoma.